The abstract is read at the publisher; the summary is JClub's.
Human implementation was documented for 31 of 209 NIH SBIR/STTR-funded neurosurgical technologies (14.8%, Wilson 95% CI 10.7%–20.3%) across fiscal years 2005–2020.
- Why it matters: The study addresses uncertainty about how frequently specific NIH-funded neurosurgical devices or procedural technologies reach documented use in living humans, and in what clinical or evaluation settings.
- What they did: Using a retrospective public-source cohort of 209 technologies and 221 award families (453 applications; $206,825,343) from 2005–2020, the authors required living-human use or a supported direct extension, with evidence sought through October 8, 2026.
- The result: Documented settings included neurosurgical-scope care (26), other clinical care (2), mixed surgical cohorts (1), and nonclinical human evaluation (2); Phase II support showed higher confirmation than Phase I only (21/98 vs 10/111).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.